ADRYANNA RUIZ: Open Payments
NPI 1801285762 · SOUTH MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,104 in 52 payments from 11 companies in 2025. Trend: 2023 $869 · 2024 $1,279 · 2025 $1,104
Food & beverage: $1,104
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 15 | $260 |
| ViiV Healthcare Company | 10 | $220 |
| Gilead Sciences, Inc. | 7 | $181 |
| Merck Sharp & Dohme LLC | 5 | $139 |
| PFIZER INC. | 5 | $102 |
| ABBVIE INC. | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Melinta Therapeutics, LLC | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Napo Pharmaceuticals Inc | 1 | $20 |
Products named: VOQUEZNA, DOVATO, PIFELTRO, UBRELVY, ELIQUIS, Biktarvy, FARXIGA, GARDASIL 9.
Industry payments across FL — which companies pay providers there.
